Robert Kwiatkowski,
Vice President, Infectious Disease R&D,
Cepheid
Dr. Robert (Bob) Kwiatkowski is currently Vice President of Research and Development for Infectious Diseases at Cepheid in Sunnyvale CA. Bob has a PhD from The Johns Hopkins University and has been involved in molecular diagnostic test development for nearly two decades in both established and startup companies including Becton Dickinson, Third Wave Technologies, and Siemens prior to Cepheid. He is listed as a co-inventor on 14 US patents and has lead teams that have launched tests for HIV, HCV, HPV, Mycobacteria tuberculosis, Chlamydia, Gonorrhea, Flu/RSV, Norovirus, and Cystic Fibrosis among others.
|
|
|
Add to Calendar ▼2014-09-19 08:30:002014-09-19 09:30:00Europe/LondonImpact of Decentralized Molecular Testing for Tuberculosis: a Global PerspectivePoint-of-Care Diagnostics World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
